This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Cord Blood Transplantation in Patients With Advanc...
Clinical trial

Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies (LYMPHCORD)

Read time: 1 mins
Last updated:17th Oct 2013
Overall survival at one year. Efficacy >60%, rejection rate <20%. inclusion criteria: age: 18-65 years old, no sibling or unrelated donor identified, low grade non-hodgkin lymphoma in third line (who already received at least one autologous transplantation); hodgkin lymphoma in early relapse (><1 year), who received at least one autologous transplantation and sensible to chemotherapy and cll with 17p deletion or in relapse less than 2 year after a fludarabine nbased regimen or in relapse after one autologous transplantation.>
Category Value
Study start date 2013-10-17

View full details